Published in J Biol Chem on October 16, 1998
The regulation of T cell homeostasis and autoimmunity by T cell-derived LIGHT. J Clin Invest (2001) 1.82
Structure-based mutagenesis of herpes simplex virus glycoprotein D defines three critical regions at the gD-HveA/HVEM binding interface. J Virol (2003) 1.78
A crucial role for HVEM and BTLA in preventing intestinal inflammation. J Exp Med (2008) 1.67
Targeting the primary tumor to generate CTL for the effective eradication of spontaneous metastases. J Immunol (2007) 1.60
The protein kinase PKR: a molecular clock that sequentially activates survival and death programs. EMBO J (2004) 1.29
Localization of the gD-binding region of the human herpes simplex virus receptor, HveA. J Virol (2001) 1.21
Modulation of T-cell responses to alloantigens by TR6/DcR3. J Clin Invest (2001) 1.16
Regulation of inflammation, autoimmunity, and infection immunity by HVEM-BTLA signaling. J Leukoc Biol (2010) 1.15
Herpes simplex virus glycoprotein D interferes with binding of herpesvirus entry mediator to its ligands through downregulation and direct competition. J Virol (2010) 1.07
Suppression by apoptotic cells defines tumor necrosis factor-mediated induction of glomerular mesangial cell apoptosis by activated macrophages. Am J Pathol (2001) 1.05
Fas ligand-induced murine pulmonary inflammation is reduced by a stable decoy receptor 3 analogue. Immunology (2003) 1.03
Herpesvirus entry mediator (TNFRSF14) regulates the persistence of T helper memory cell populations. J Exp Med (2011) 1.01
Immunoregulation by tumor necrosis factor superfamily member LIGHT. Immunol Rev (2009) 0.98
Signal transduction by tumour necrosis factor and tumour necrosis factor related ligands and their receptors. Ann Rheum Dis (1999) 0.96
TRAF2 plays a key, nonredundant role in LIGHT-lymphotoxin beta receptor signaling. Mol Cell Biol (2005) 0.96
Regulating the mucosal immune system: the contrasting roles of LIGHT, HVEM, and their various partners. Semin Immunopathol (2009) 0.96
VISTA is a novel broad-spectrum negative checkpoint regulator for cancer immunotherapy. Cancer Immunol Res (2014) 0.94
HVEM signalling promotes colitis. PLoS One (2011) 0.92
The nature of activatory and tolerogenic dendritic cell-derived signal II. Front Immunol (2013) 0.91
Turning on LIGHT. J Clin Invest (2001) 0.90
Genetic evidence that intratumoral T-cell proliferation and activation are associated with recurrence and survival in patients with resected colorectal liver metastases. Cancer Immunol Res (2015) 0.89
Dancing with the enemy: the interplay of herpes simplex virus with dendritic cells. Clin Exp Immunol (2005) 0.89
CD160 activation by herpesvirus entry mediator augments inflammatory cytokine production and cytolytic function by NK cells. J Immunol (2013) 0.88
Targeting tumors with LIGHT to generate metastasis-clearing immunity. Cytokine Growth Factor Rev (2008) 0.87
LIGHT/TNFSF14 increases osteoclastogenesis and decreases osteoblastogenesis in multiple myeloma-bone disease. Oncotarget (2014) 0.86
Soluble receptor (DcR3) and cellular inhibitor of apoptosis-2 (cIAP-2) protect human cytotrophoblast cells against LIGHT-mediated apoptosis. Am J Pathol (2004) 0.85
Herpesvirus entry mediator regulates hypoxia-inducible factor-1α and erythropoiesis in mice. J Clin Invest (2011) 0.85
Differential expression of LIGHT and its receptors in human placental villi and amniochorion membranes. Am J Pathol (2002) 0.85
Neutralization of LIGHT ameliorates acute dextran sodium sulphate-induced intestinal inflammation. Immunology (2009) 0.83
TNF superfamily: costimulation and clinical applications. Cell Biol Int (2009) 0.83
CD160 isoforms and regulation of CD4 and CD8 T-cell responses. J Transl Med (2014) 0.81
Aberrant expression and function of death receptor-3 and death decoy receptor-3 in human cancer. Exp Ther Med (2011) 0.81
The role of costimulatory receptors of the tumour necrosis factor receptor family in atherosclerosis. J Biomed Biotechnol (2011) 0.81
Herpes virus entry mediator (HVEM) modulates proliferation and activation of regulatory T cells following HSV-1 infection. Microbes Infect (2014) 0.81
Critical roles for LIGHT and its receptors in generating T cell-mediated immunity during Leishmania donovani infection. PLoS Pathog (2011) 0.81
Increased plasma LIGHT levels in patients with atopic dermatitis. Clin Exp Immunol (2012) 0.81
Binding Studies of TNF Receptor Superfamily (TNFRSF) Receptors on Intact Cells. J Biol Chem (2015) 0.80
The interaction of monocytes with rheumatoid synovial cells is a key step in LIGHT-mediated inflammatory bone destruction. Immunology (2008) 0.80
Therapeutic blockade of LIGHT interaction with herpesvirus entry mediator and lymphotoxin β receptor attenuates in vivo cytotoxic allogeneic responses. Transplantation (2014) 0.77
Herpesvirus Entry Mediator on Radiation-Resistant Cell Lineages Promotes Ocular Herpes Simplex Virus 1 Pathogenesis in an Entry-Independent Manner. MBio (2015) 0.77
Herpesvirus entry mediator (HVEM) attenuates signals mediated by the lymphotoxin β receptor (LTβR) in human cells stimulated by the shared ligand LIGHT. Mol Immunol (2014) 0.76
The control of tissue fibrosis by the inflammatory molecule LIGHT (TNF Superfamily member 14). Pharmacol Res (2015) 0.76
Innate lymphotoxin receptor mediated signaling promotes HSV-1 associated neuroinflammation and viral replication. Sci Rep (2015) 0.75
Lentivirus-mediated LIGHT overexpression inhibits human colorectal carcinoma cell growth in vitro and in vivo. Oncol Lett (2013) 0.75
Neuron-specific SALM5 limits inflammation in the CNS via its interaction with HVEM. Sci Adv (2016) 0.75
Increased Serum LIGHT Levels Correlate with Disease Progression and Severity of Interstitial Pneumonia in Patients with Dermatomyositis: A Case Control Study. PLoS One (2015) 0.75
The canonical and unconventional ligands of the herpesvirus entry mediator. Adv Exp Med Biol (2011) 0.75
LIGHT Elevation Enhances Immune Eradication of Colon Cancer Metastases. Cancer Res (2017) 0.75
Axl acts as a tumor suppressor by regulating LIGHT expression in T lymphoma. Oncotarget (2017) 0.75
A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature (1995) 11.89
SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett (1995) 9.62
Early steps of lymphocyte activation bypassed by synergy between calcium ionophores and phorbol ester. Nature (1985) 5.06
Crystal structure of an HIV-binding recombinant fragment of human CD4. Nature (1990) 4.81
Energetics of the HIV gp120-CD4 binding reaction. Proc Natl Acad Sci U S A (2000) 4.44
Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. J Biol Chem (1998) 3.88
Immunolocalization of the dengue virus nonstructural glycoprotein NS1 suggests a role in viral RNA replication. Virology (1996) 3.60
Malpractice claims against family physicians are the best doctors sued more? J Fam Pract (1999) 2.87
Binding of phosphatidylinositol-3-OH kinase to CD28 is required for T-cell signalling. Nature (1994) 2.63
A new nomenclature for IL-1-family genes. Trends Immunol (2001) 2.57
Identification of mitogen-activated protein (MAP) kinase-activated protein kinase-3, a novel substrate of CSBP p38 MAP kinase. J Biol Chem (1996) 2.55
Determination of rate and equilibrium binding constants for macromolecular interactions using surface plasmon resonance: use of nonlinear least squares analysis methods. Anal Biochem (1993) 2.51
Natural occurrence of cross-linked vaccinia virus deoxyribonucleic acid. J Virol (1970) 2.41
Dominant missense mutations in a novel yeast protein related to mammalian phosphatidylinositol 3-kinase and VPS34 abrogate rapamycin cytotoxicity. Mol Cell Biol (1993) 2.40
Tumor necrosis factor-alpha expression in ischemic neurons. Stroke (1994) 2.37
Application of finite element analysis in implant dentistry: a review of the literature. J Prosthet Dent (2001) 2.33
Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration. J Biol Chem (1998) 2.32
Pyridinyl imidazole inhibitors of p38 mitogen-activated protein kinase bind in the ATP site. J Biol Chem (1997) 2.28
Crystal structure of the extracellular domain from P0, the major structural protein of peripheral nerve myelin. Neuron (1996) 2.25
Identification and initial characterization of four novel members of the interleukin-1 family. J Biol Chem (2000) 2.24
A statement on the generalist physician from the American Boards of Family Practice and Internal Medicine. JAMA (1994) 2.16
Structural proteins of simian virus 40: phosphoproteins. J Virol (1972) 2.16
Cloning of a type I cytokine receptor most related to the IL-2 receptor beta chain. Proc Natl Acad Sci U S A (2000) 2.16
5-lipoxygenase inhibitory activity of zileuton. J Pharmacol Exp Ther (1991) 2.14
Acquisition of sensitivity of stress-activated protein kinases to the p38 inhibitor, SB 203580, by alteration of one or more amino acids within the ATP binding pocket. J Biol Chem (1998) 2.12
Role of CSB/p38/RK stress response kinase in LPS and cytokine signaling mechanisms. J Leukoc Biol (1996) 2.09
A Clinical Study of Fifty-four Cases of Occlusion of the Central Artery of the Retina and its Branches: (Section of Ophthalmology). Proc R Soc Med (1937) 2.07
Diagnosis and initial management of blunt pancreatic trauma: guidelines from a multiinstitutional review. Ann Surg (1998) 2.07
A newly identified member of the tumor necrosis factor receptor superfamily with a wide tissue distribution and involvement in lymphocyte activation. J Biol Chem (1997) 2.00
Novel homologues of CSBP/p38 MAP kinase: activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles. Biochem Biophys Res Commun (1997) 1.99
The kinetics of interleukin 1 secretion from activated monocytes. Differences between interleukin 1 alpha and interleukin 1 beta. J Biol Chem (1988) 1.95
Processing of precursor interleukin 1 beta and inflammatory disease. J Biol Chem (1990) 1.94
Activation of the p38 mitogen-activated protein kinase by type I interferons. J Biol Chem (1999) 1.94
Structural basis of inhibitor selectivity in MAP kinases. Structure (1998) 1.89
Performances of family practice diplomates on successive mandatory recertification examinations. Acad Med (1993) 1.75
Activity of recombinant dengue 2 virus NS3 protease in the presence of a truncated NS2B co-factor, small peptide substrates, and inhibitors. J Biol Chem (2001) 1.72
Intragenic amplification and divergence in the mouse alpha-fetoprotein gene. Nature (1981) 1.69
A simple device for fractionating density gradients. Anal Biochem (1972) 1.68
Temperature-sensitive differential affinity of TRAIL for its receptors. DR5 is the highest affinity receptor. J Biol Chem (2000) 1.68
A comparison of the substrate specificity of MAPKAP kinase-2 and MAPKAP kinase-3 and their activation by cytokines and cellular stress. FEBS Lett (1996) 1.68
cDNA sequence, protein structure, and chromosomal location of the human gene for poly(ADP-ribose) polymerase. Proc Natl Acad Sci U S A (1987) 1.66
Structural analysis of the human immunodeficiency virus-binding domain of CD4. Epitope mapping with site-directed mutants and anti-idiotypes. J Exp Med (1989) 1.60
Characterization and immunological identification of cDNA clones encoding two human DNA topoisomerase II isozymes. Proc Natl Acad Sci U S A (1989) 1.58
Humoral immunity to adeno-associated virus type 2 vectors following administration to murine and nonhuman primate muscle. J Virol (2000) 1.57
Self-activation of guanosine triphosphatase activity by oligomerization of the bacterial cell division protein FtsZ. Biochemistry (1999) 1.53
Role of intra- and extracellular calcium in histamine release from rat peritoneal mast cells. Agents Actions (1981) 1.53
Iodine-131 in breast milk following therapy for thyroid carcinoma. J Nucl Med (1994) 1.51
Transcriptional control of the expression of mouse globin genes in myeloma x erythroleukemia cell hybrids. Somatic Cell Genet (1982) 1.50
Stable high-level expression of heterologous genes in vitro and in vivo by noncytopathic DNA-based Kunjin virus replicon vectors. J Virol (2000) 1.49
Celecoxib reduces microvessel density in patients treated with nasopharyngeal carcinoma and induces changes in gene expression. Ann Oncol (2006) 1.48
The Rac1/p38 mitogen-activated protein kinase pathway is required for interferon alpha-dependent transcriptional activation but not serine phosphorylation of Stat proteins. J Biol Chem (2000) 1.47
Identification of SAF-2, a novel siglec expressed on eosinophils, mast cells, and basophils. J Allergy Clin Immunol (2000) 1.46
Differential activation of the ERK, JNK, and p38 mitogen-activated protein kinases by CD40 and the B cell antigen receptor. J Immunol (1996) 1.45
Precise location of sequential dengue virus subcomplex and complex B cell epitopes on the nonstructural-1 glycoprotein. Arch Virol (1994) 1.43
Semliki forest virus temperature-sensitive mutants: isolation and characterization. Virology (1969) 1.42
The interaction of intercalating drugs with nucleic acids. Annu Rev Biophys Bioeng (1981) 1.42
Reciprocal expression of the TNF family receptor herpes virus entry mediator and its ligand LIGHT on activated T cells: LIGHT down-regulates its own receptor. J Immunol (2000) 1.42
Prenatal care--a serious national dilemma. J Am Board Fam Pract (1990) 1.41
Construction and expression in vivo of an internally deleted mouse alpha-fetoprotein gene: presence of a transcribed Alu-like repeat within the first intervening sequence. Nucleic Acids Res (1982) 1.40
Sudden Blindness. Br Med J (1939) 1.39
Anomalies associated with myelodysplasia. Urology (1992) 1.39
Induction of alpha-fetoprotein synthesis in differentiating F9 teratocarcinoma cells is accompanied by a genome-wide loss of DNA methylation. Mol Cell Biol (1984) 1.39
Use of protein unfolding studies to determine the conformational and dimeric stabilities of HIV-1 and SIV proteases. Biochemistry (1992) 1.38
Liposomal malaria vaccine in humans: a safe and potent adjuvant strategy. Proc Natl Acad Sci U S A (1992) 1.37
Immobilization chemistries suitable for use in the BIAcore surface plasmon resonance detector. Anal Biochem (1992) 1.35
Cloning, expression, and pharmacological characterization of a novel human histamine receptor. Mol Pharmacol (2001) 1.34
Expression pattern of human P2Y receptor subtypes: a quantitative reverse transcription-polymerase chain reaction study. Biochim Biophys Acta (2001) 1.33
Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1 beta precursor and loses affinity for IL-1 receptor antagonist. Proc Natl Acad Sci U S A (1995) 1.32
Crystal structure of beta-ketoacyl-acyl carrier protein synthase III. A key condensing enzyme in bacterial fatty acid biosynthesis. J Biol Chem (1999) 1.31
Regulation of stress-induced cytokine production by pyridinylimidazoles; inhibition of CSBP kinase. Bioorg Med Chem (1997) 1.31
The TNF superfamily members LIGHT and CD154 (CD40 ligand) costimulate induction of dendritic cell maturation and elicit specific CTL activity. J Immunol (2001) 1.31
Immunoaffinity purification of native dimer forms of the flavivirus non-structural glycoprotein, NS1. J Virol Methods (1990) 1.31
Production of dimer-specific and dengue virus group cross-reactive mouse monoclonal antibodies to the dengue 2 virus non-structural glycoprotein NS1. J Gen Virol (1991) 1.30
Human acyl-CoA:diacylglycerol acyltransferase is a tetrameric protein. Biochem J (2001) 1.30
Interleukin-1 beta mRNA expression in ischemic rat cortex. Stroke (1993) 1.30
Calcium pools involved in histamine release from rat mast cells. Int Arch Allergy Appl Immunol (1980) 1.30
The ABRF-MIRG'02 study: assembly state, thermodynamic, and kinetic analysis of an enzyme/inhibitor interaction. J Biomol Tech (2003) 1.29
A rapid and quantitative method for the determination of interleukin-1 alpha and -beta mRNA expression in human monocytes and macrophages. J Immunol Methods (1989) 1.29
Major histocompatibility complex class I molecules internalized via coated pits in T lymphocytes. Nature (1987) 1.28
Experimental brain injury induces differential expression of tumor necrosis factor-alpha mRNA in the CNS. Brain Res Mol Brain Res (1996) 1.28
Virion-bound protein kinase in Semliki forest and Sindbis viruses. J Virol (1974) 1.28